Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedMay 24, 2017PGE1/PAP 10/30 5ML MDV MCG/MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0734-2017Class IITerminatedMay 24, 2017PGE1/CPZ 5ML MDV 20MCG/1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0733-2017Class IITerminatedMay 24, 2017PGE1 5ML MDV INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0732-2017Class IITerminatedMay 24, 2017PGE1 MDV 20MCG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0731-2017Class IITerminatedMay 24, 2017PAPAVERINE/PHENT 5ML MDV 30/1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0730-2017Class IITerminatedMay 24, 2017PAPAVERINE/PHENT 5ML MDV 30/0.5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0729-2017Class IITerminatedMay 24, 2017HYDROXO-B12 5ML PBF MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0728-2017Class IITerminatedMay 24, 2017HYDROXO-B12 PBF MDV 10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0727-2017Class IITerminatedMay 24, 2017HYDROXO-B12 30ML PBF MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0726-2017Class IITerminatedMay 24, 2017HYDROXO-B12 5ML PBF MDV 1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0725-2017Class IITerminatedMay 24, 2017HYDROXO-B12 10ML PBF MDV 5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0724-2017Class IITerminatedMay 24, 2017HYDROXO-B12 INH PF GV 5MG/ML SOLNLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0723-2017Class IITerminatedMay 24, 2017HYDROXO-B12 1ML SDV 10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0722-2017Class IITerminatedMay 24, 2017HYDROXO-B12 *1ML* SDV 1MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0721-2017Class IITerminatedMay 24, 2017HCG *10ML* MDV 500U/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0720-2017Class IITerminatedMay 24, 2017FOLINIC ACID MDV INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0719-2017Class IITerminatedMay 24, 2017FOLINIC ACID MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0718-2017Class IITerminatedMay 24, 2017FOLIC ACID 1ML SDV 10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0717-2017Class IITerminatedMay 24, 2017FERR GLUC/PROCAINE 10ML MDV 60/10MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0716-2017Class IITerminatedMay 24, 2017DMSO 6.25% OPHTHLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0715-2017Class IITerminatedMay 24, 2017DMPS ACID *5ML* SDV 50MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0714-2017Class IITerminatedMay 24, 2017CO-Q-10 OIL 20ML MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0713-2017Class IITerminatedMay 24, 2017ATROPINE SULFATE 0.5% OPHTHLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0712-2017Class IITerminatedMay 24, 2017ATROPINE SULFATE 0.01% OPHTHLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0711-2017Class IITerminatedMay 24, 20175-MTHF SDV 5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0710-2017Class IITerminatedMay 24, 20175-MTHF 10ML SDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0709-2017Class IITerminatedMay 24, 20175-MTHF 10ML MDVLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0708-2017Class IITerminatedMay 24, 20175-MTHF *10ML* MDV 5MG/ML INJLack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.Key Pharmacy and Compounding Center · D-0707-2017Class IITerminatedMay 17, 2017Clozapine Tablets USPMicrobial Contamination of Non-Sterile ProductsTeva Pharmaceuticals USA · D-0705-2017Class IIITerminatedMay 17, 2017MozobilLabeling: Incorrect or Missing Package InsertSanofi-Aventis U.S. LLC · D-0704-2017Class IIITerminatedMay 17, 2017PrednisoLONE Oral Solution USPFailed Stability SpecificationsTeva Pharmaceuticals USA · D-0703-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0702-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0701-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0700-2017Class IIITerminatedMay 17, 2017Olanzapine TabletsFailed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).Sun Pharmaceutical Industries, Inc. · D-0699-2017Class IITerminatedMay 17, 2017Buprenorphine HCI InjectionCrystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose...PAR Sterile Products LLC · D-0698-2017Class IIITerminatedMay 17, 2017IC-GreenProduct is being recalled due to low pH value.Akorn, Inc. · D-0697-2017Class IITerminatedMay 10, 2017Sulfamethoxazole and Trimethoprim Oral SuspensionFailed Dissolution SpecificationsAkorn Inc · D-0696-2017Class IIITerminatedMay 10, 2017Zinc Oxide Paste 25%Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.Fagron, Inc · D-0695-2017Class IIITerminatedMay 10, 2017Allergy Relief Diphenhydramine HCl 25 mgSubpotent: This product is being recalled due to low out of specification assay results at the 9 month time point.P & L Development, LLC · D-0694-2017